Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies

Citation
L. Bubendorf et al., Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies, J PATHOLOGY, 195(1), 2001, pp. 72-79
Citations number
11
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
JOURNAL OF PATHOLOGY
ISSN journal
00223417 → ACNP
Volume
195
Issue
1
Year of publication
2001
Pages
72 - 79
Database
ISI
SICI code
0022-3417(200109)195:1<72:TM(TMP>2.0.ZU;2-0
Abstract
Tissue microarray (TMA) technology allows a massive acceleration of studies correlating molecular in situ findings with clinico-pathological informati on. In this technique, cylindrical tissue samples are taken from up to 1000 different archival tissue blocks and subsequently placed into one empty 'r ecipient' paraffin block. Sections from TMA blocks can be used for all diff erent types of in situ tissue analyses including immunohistochemistry and i n situ hybridization. Multiple studies have demonstrated that findings obta ined on TMAs are highly representative of their donor tissues, despite the small size of the individual specimens (diameter 0.6 mm). It is anticipated that TMAs will soon become a widely used tool for all types of tissue-base d research. The availability of TMAs containing highly characterized tissue s will enable every researcher to perform studies involving thousands of tu mours rapidly. Therefore, TMAs will lead to a significant acceleration of t he transition of basic research findings into clinical applications. Copyri ght (C) 2001 John Wiley & Sons, Ltd.